Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
Yonsei Medical Journal
;
: 196-198, 2011.
Article
Dans Anglais
| WPRIM
| ID: wpr-136363
ABSTRACT
Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of complete atrioventricular block while receiving bortezomib. We immediately stopped bortezomib, and after inserting a permanent VDD pacemaker, the patients' symptoms disappeared.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pyrazines
/
Acides boroniques
/
Bloc atrioventriculaire
/
Myélome multiple
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Yonsei Medical Journal
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS